Álvarez-Torres MDM, Juan-Albarracín J, Fuster-Garcia E, Bellvís-Bataller F, Lorente D, Reynés G, Font de Mora J, Aparici-Robles F, Botella C, Muñoz-Langa J, Faubel R, Asensio-Cuesta S, García-Ferrando GA, Chelebian E, Auger C, Pineda J, Rovira A, Oleaga L, Mollà-Olmos E, Revert AJ, Tshibanda L, Crisi G, Emblem KE, Martin D, Due-Tønnessen P et al. (2019)
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study
J Magn Reson Imaging
DOI 10.1002/jmri.26958, PubMed 31654541

Gerstner E, Emblem KE, Chang K, Vakulenko-Lagun B, Yen YF, Beers AL, Dietrich J, Plotkin SR, Catana C, Hooker JM, Duda DG, Rosen B, Kalpathy-Cramer J, Jain RK, Batchelor T (2019)
Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-19-1739, PubMed 31558474

Due-Tønnessen P, Groote I (2019)
Like pearls on a string
Tidsskr Nor Laegeforen, 139 (12)
DOI 10.4045/tidsskr.19.0203, PubMed 31502799